acetazolamide injection, powder, lyophilized, for solution
xgen pharmaceuticals djb, inc. - acetazolamide sodium (unii: 429zt169uh) (acetazolamide - unii:o3fx965v0i) - acetazolamide 500 mg in 5 ml - for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. hypersensitivity to acetazolamide or any excipients in the formulation. since acetazolamide is a sulfonamide derivative, cross sensitivity between acetazolamide, sulfonamides and other sulfonamide derivatives is possible. acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. it is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. long-term administration of acetazolamide is contraindicated in patients with chronic noncongestive angle-closure glaucoma since it may permit organic closure of the angle to occur while the worsening glaucoma is masked by lowered intraocular pressure.
acetazolamide- acetazolamide tablet
pd-rx pharmaceuticals, inc. - acetazolamide (unii: o3fx965v0i) (acetazolamide - unii:o3fx965v0i) - acetazolamide 250 mg - for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. acetazolamide tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent. acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. it is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. long-term administration of acetazolamide is contraindicated in patients with chroni
acetazolamide tablets 250mg
zista pharma limited suite g19, the business & technology centre (btc), bessemer drive, stevenage, herts sg1 2dx, united kingdom - acetazolamide - tablet - acetazolamide 250 mg - ophthalmologicals
acetazolamide crescent 250 mg tablets
crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - acetazolamide - tablet - acetazolamide 250 mg - ophthalmologicals
acetazolamide tablet
aa pharma inc - acetazolamide - tablet - 250mg - acetazolamide 250mg - carbonic anhydrase inhibitors
acetazolamide capsule extended release
kaiser foundation hospitals - acetazolamide (unii: o3fx965v0i) (acetazolamide - unii:o3fx965v0i) - acetazolamide 500 mg
acetazolamide 250mg tablets
sandoz ltd - acetazolamide - oral tablet - 250mg
acetazolamide 250mg tablets
alliance healthcare (distribution) ltd - acetazolamide - oral tablet - 250mg
acetazolamide 250mg tablets
a a h pharmaceuticals ltd - acetazolamide - oral tablet - 250mg
acetazolamide 250mg tablets
de pharmaceuticals - acetazolamide - oral tablet - 250mg